Physician profile
Oya Yildirim
NPI 1295383388
$3,564.22
in general payments reported to CMS, 2019-2025
16 companies · $172 in 2025
The $172 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $138 · 2022: $1,154 · 2023: $1,009 · 2024: $1,091 · 2025: $172.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,272.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,272.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,376.07 | 2021-2024 | Intellis Adaptivestim, Synchromedii |
| Boston Scientific Corporation | $946.92 | 2021-2024 | Superion Indirect Decompression System, Wavewriter Alpha Prime 16 |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $344.17 | 2022-2024 | Relistor |
| Globus Medical, INC. | $319.69 | 2022-2025 | Senza |
| 4web, INC. | $138.14 | 2023 | Spine Truss System |
| Relievant Medsystems, INC. | $115.28 | 2023 | Intracept |
| Grt US Holding, INC. | $76.42 | 2022 | |
| Electronic Waveform Lab, INC. | $66.50 | 2022 | |
| Foundation Fusion Solutions, LLC | $35.43 | 2024 | |
| Nevro Corp. | $29.05 | 2023 | Senza |
| Amgen INC. | $25.21 | 2022 | |
| Averitas Pharma INC. | $21.73 | 2023 | Qutenza |
| Horizon Therapeutics Plc | $19.00 | 2022 | |
| Bioventus LLC | $18.17 | 2025 | Nexus-10 Mkii |
| Trevena, INC. | $16.82 | 2023 | Olinvyk |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotronik Nro, INC. | $15.62 | 2024 | Prospera |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Oya Yildirim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.